Literature DB >> 8910918

Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats.

B L Pool-Zobel1, C Neudecker, I Domizlaff, S Ji, U Schillinger, C Rumney, M Moretti, I Vilarini, R Scassellati-Sforzolini, I Rowland.   

Abstract

Lactic acid bacteria (LAB) are proposed to have several beneficial effects, including the inactivation of carcinogens. We have studied the potential of Lactobacillus acidophilus (from a commercially available yogurt), Lactobacillus gasseri (P79), Lactobacillus confusus (DSM20196), Streptococcus thermophilus (NCIM 50083), Bifidobacterium breve and Bifidobacterium longum (from human infant stool) to prevent the induction of DNA damage by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 7.5 mg/kg body wt) in colon cells of the rat. Using the new technique of single cell microgel electrophoresis, all investigated strains were antigenotoxic toward MNNG after a single dose of 10(10) viable cells/kg body wt p.o. eight hours before the carcinogen. One-half and one-tenth of this initial dose resulted in a loss of protective activity. High doses of heat-treated L. acidophilus strains were also not antigenotoxic. One mechanism of the preventive effect could be that bacterial metabolites or components are responsible. Accordingly, selected examples were investigated in vitro in colon cells of the rat. Metabolically active L. acidophilus cells, as well as an acetone extract of the culture, prevented MNNG-induced DNA damage. Different cell fractions from L. acidophilus (cytoplasm, cell wall skeleton, cell wall) were devoid of antigenotoxic activity, whereas the peptidoglycan fraction and whole freeze-dried cells were antigenotoxic. As a second carcinogen, 1,2-dimethylhydrazine (DMH) was used. A dose- and time-response study was first performed to assess the effects of DMH in several segments of the gastrointestinal (GI) tract. Exposure for 16 hours to 15 or 25 mg DMH/kg body wt p.o. induced DNA damage in cells of the distal colon of rats, whereas no cytotoxicity was seen. Pretreatment orally with LAB on four consecutive mornings before DMH gavage (8 hours after the last LAB application) revealed that L. acidophilus, L. confusus, L. gasseri, B. longum, and B. breve inhibited the genotoxic effect of DMH. One of four S. thermophilus and one of three Lactobacillus delbrueckeii ssp. bulgaricus strains were also protective. Heat-treated L. acidophilus did not inhibit DMH-induced genotoxicity. A few aliquots of the colon cells were processed immunohistochemically for the presence of the "proliferation cell nuclear antigen" (PCNA). DMH treatment did not increase PCNA, nor was there any modulation by LAB. The effect of L. acidophilus on foreign compound-metabolizing enzymes (Phase I and Phase II) in liver and colon cells of rats revealed only one parameter to be modulated, namely, a two- to three-fold increase in the levels of NADPH-cytochrome P-450 reductase. The meaning of this finding, in terms of possible chemoprevention by LAB, remains unclear. In conclusion, our studies show that most, but not all, LAB tested could strongly inhibit genotoxicity in the GI tract of the rat and that viable LAB organisms are required for the protective effect in vivo. The comet assay technique is a powerful tool to elucidate such in vivo antigenotoxic activities in tumor target tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910918     DOI: 10.1080/01635589609514492

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  35 in total

1.  Antimutagenicity of milk fermented by Enterococcus faecium.

Authors:  A Belicová; J Krajcovic; J Dobias; L Ebringer
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

2.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

Review 3.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 4.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

5.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 6.  The potential hazards of Aspergillus sp. in foods and feeds, and the role of biological treatment: a review.

Authors:  Sheikh Imranudin Sheikh-Ali; Akil Ahmad; Siti-Hamidah Mohd-Setapar; Zainul Akmal Zakaria; Norfahana Abdul-Talib; Aidee Kamal Khamis; Md Enamul Hoque
Journal:  J Microbiol       Date:  2014-10-01       Impact factor: 3.422

Review 7.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

8.  Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel.

Authors:  Xiao-dong Pan; Fen-qin Chen; Tian-xing Wu; Hong-gang Tang; Zhan-yu Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

Review 9.  Gastrointestinal microflora, food components and colon cancer prevention.

Authors:  Cindy D Davis; John A Milner
Journal:  J Nutr Biochem       Date:  2009-08-27       Impact factor: 6.048

10.  Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity.

Authors:  Mitsuko L Yamamoto; Irene Maier; Angeline Tilly Dang; David Berry; Jared Liu; Paul M Ruegger; Jiue-In Yang; Phillip A Soto; Laura L Presley; Ramune Reliene; Aya M Westbrook; Bo Wei; Alexander Loy; Christopher Chang; Jonathan Braun; James Borneman; Robert H Schiestl
Journal:  Cancer Res       Date:  2013-07-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.